L-Ergothioneine Powder: A Miraculous Antioxidant

As a specialized B2B supplier of high-purity bioactive ingredients, we offer Pharmaceutical-Grade L-Ergothioneine (EGT) Powder (≥98% purity) - a rare, naturally occurring sulfur-containing amino acid that has been recognized as one of the most powerful and stable antioxidants available. With a unique cellular transporter (OCTN1) that selectively accumulates EGT in tissues exposed to high oxidative stress - including the liver, kidneys, brain, and eyes - ergothioneine delivers targeted cytoprotection unmatched by conventional antioxidants. The global EGT market is projected to grow from USD 74.75 million in 2025 to USD 419 million by 2032, representing an exceptional CAGR of 28.2% , driven by surging demand for science-backed longevity, cognitive health, and skin wellness ingredients.

What is L-Ergothioneine?

L-Ergothioneine (CAS 497-30-3; molecular formula C₉H₁₅N₃O₂S; molecular weight 229.30 g/mol) is a naturally occurring amino acid and thiourea derivative of histidine, containing a sulfur atom on the imidazole ring. It is synthesized exclusively by certain fungi, Actinobacteria, and Cyanobacteria, with humans acquiring it solely through dietary intake - primarily from mushrooms.

The OCTN1 Transporter: EGT's Unique Cellular Targeting Mechanism

Unlike other antioxidants that are distributed throughout the body without specificity, ergothioneine is actively transported into cells via the organic cation transporter novel type 1 (OCTN1, encoded by the SLC22A4 gene). This transporter is expressed at high levels in tissues most vulnerable to oxidative damage, including:

This selective accumulation mechanism enables EGT to exert its antioxidant and cytoprotective effects precisely where they are needed most, distinguishing it from conventional antioxidants that lack tissue specificity.

Global Market Overview: A High-Growth Ingredient with Unprecedented Momentum

The L-ergothioneine market is experiencing explosive growth, driven by increasing consumer demand for natural, science-backed antioxidants that support healthy aging, immune function, and cellular protection.

Market Size & Projections

Note: Market size variations reflect differing scope definitions. Global sales of EGT reached approximately 3,271.4 kg in 2025, with an average price of USD 23.4 per gram.

Key Market Drivers

• Growing Demand for Natural Antioxidants: Increased consumer awareness of oxidative stress-related diseases and preventive healthcare has fueled interest in EGT's potent cytoprotective and anti-inflammatory properties

• Clean-Label and Science-Backed Wellness: The shift toward clean-label, plant-based, and scientifically validated products supports EGT's expansion across nutraceutical, functional food, and cosmetic industries

• Advances in Production Technology: Fermentation and biosynthesis technologies have improved the scalability and cost-effectiveness of EGT production, supporting broader commercial adoption

• Expanding Clinical Evidence: A growing body of human clinical trials published in 2025–2026 has validated EGT's benefits for cognitive function, sleep quality, skin health, and cellular aging

• Regulatory Clarity: FDA GRAS status and EU Novel Food authorization provide regulatory confidence for global market access

Regional Production Landscape

China has emerged as a key global producer of L-ergothioneine, with manufacturers utilizing advanced fermentation and biosynthesis technologies to achieve high-purity (≥98%) production at commercial scale. The country's vertically integrated supply chains and cost-effective production capabilities offer B2B buyers significant advantages in quality, consistency, and pricing.

Clinically Validated Health Benefits (2025–2026 Research)

The scientific evidence base for ergothioneine has expanded dramatically in 2025–2026, with multiple high-quality human clinical trials validating its efficacy across multiple health categories.

1. Cognitive Function & Memory Support

A randomized, placebo-controlled trial published in 2025 evaluated 147 adults aged 55–79 with subjective memory complaints. Participants received either a placebo or 10 mg or 25 mg of L-ergothioneine daily for 16 weeks.

Key Findings:

• Plasma ergothioneine increased 3- to 6-fold in the low-dose group and 6- to 16-fold in the high-dose group by weeks 4 and 16, confirming excellent bioavailability

• Subjective prospective memory and sleep initiation improved dose-dependently, with significant effects at 25 mg (p < 0.05)

• Reaction time improved in both treatment groups

• Composite memory scores increased by week 4 in the 25 mg group

• Plasma ALT and AST were significantly reduced, suggesting improved liver function

• The supplement was safe and well-tolerated with no adverse events

A pilot study in older adults with mild cognitive impairment also demonstrated that ergothioneine improved performance in assessments of learning ability and memory.

2. Skin Health & Anti-Aging

An 8-week randomized, double-blind, placebo-controlled trial evaluated 66 women aged 35–59 who received either 30 mg/day of DR.ERGO® ergothioneine or placebo.

Key Findings:

• The ergothioneine group showed significantly greater improvements in:

Melanin and erythema reduction (all p < 0.01)

Skin glossiness (p < 0.01)

Elasticity (R2, R5, R7 parameters) (p < 0.01)

Wrinkle and spot reduction (p < 0.01)

• No adverse events were reported

• Continuous oral intake of ergothioneine was concluded to significantly improve skin aging parameters with excellent safety and tolerability

A 2025 study published in Free Radical Biology and Medicine further demonstrated that ergothioneine regulates the paracrine of dermal papilla cells through the SIRT1/Nrf2 pathway, antagonizing oxidative stress and natural hair follicle aging. This research indicates EGT has potent antioxidant and anti-aging functions for hair follicles, opening new therapeutic avenues for hair aging.

3. Reproductive Health & Ovarian Reserve

A pilot study investigating oral L-ergothioneine (120 mg/day) over three menstrual cycles in women with suboptimal ovarian reserve found:

• Well-tolerated with no safety concerns

• Associated with increases in serum AMH (anti-Müllerian hormone)

• Favorable shifts in the FSH/E2 profile

• Improvements in reproductive aging-related and sleep symptoms

4. Liver Function & Hepatoprotection

The 2025 clinical trial on cognitive function also observed significant reductions in plasma ALT and AST - key markers of liver health - particularly in the 25 mg group. Preclinical findings have demonstrated ergothioneine's capacity to reduce oxidative stress, attenuate hepatic inflammation, and mitigate liver injury.

5. Neuroprotection & Neurodegenerative Disease

A 2025 study published in PubMed demonstrated that ergothioneine treatment ameliorates the pathological phenotypes of Parkinson's disease models. The unique accumulation of EGT in brain tissue via the OCTN1 transporter, combined with its ability to control mitochondrial function, positions it as a promising candidate for neuroprotective formulations.

6. Telomere Length & Cellular Aging

The 2025 clinical trial was the first to investigate the effect of ergothioneine supplementation on telomere length. In female participants, a within-group increase in telomere length was observed at 10 mg. Population-based studies have previously linked higher plasma ergothioneine to longer telomeres.

7. Mitochondrial Function & Exercise Performance

Emerging research demonstrates that ergothioneine controls mitochondrial function and exercise performance via direct activation of MPST. This finding supports EGT's potential applications in sports nutrition and performance formulations.

The Science: Understanding EGT's Unique Antioxidant Mechanism

Structural Stability & Redox Properties

Unlike many antioxidants that are consumed (oxidized) during the neutralization of free radicals, ergothioneine's unique thiol-thione tautomerism provides exceptional stability. EGT can effectively scavenge reactive oxygen species (ROS), chelate transition metal ions, and protect biomolecules from oxidative damage without being rapidly depleted.

Nrf2/ARE Pathway Activation

Beyond direct free radical scavenging, EGT activates the nuclear factor erythroid 2-related factor 2/antioxidant response element (Nrf2/ARE) signaling pathway, upregulating the body's endogenous antioxidant defense systems. This dual mechanism - direct scavenging plus endogenous defense activation - provides comprehensive cellular protection.

SIRT1 Pathway Modulation

Research has demonstrated that ergothioneine regulates cellular functions through the SIRT1/Nrf2 pathway, linking EGT to the longevity-associated sirtuin family of proteins. This mechanism positions EGT alongside other longevity ingredients such as resveratrol and NMN.

Technical Specifications: Pharmaceutical-Grade Standards

Our L-ergothioneine powder meets rigorous international quality standards, ensuring batch-to-batch consistency and regulatory readiness for global markets.

Product Specifications (≥98% Purity)

Heavy Metal Limits

Available Grades

Certifications & Compliance

• Manufacturing Certifications: cGMP, ISO 9001, ISO 22000, HACCP, FSSC 22000

• Product Certifications: Kosher, Halal, Non-GMO

• Regulatory Status:

FDA GRAS: GRN 000734 received a "no questions" letter

EU Novel Food: Authorized under Regulation (EU) 2018/462

China: Pre-market approval application submitted in 2024

• Safety:

NOAEL: 800 mg/kg bw/day (subchronic toxicity study)

Well-tolerated in humans at intake levels up to 25 mg/day

Non-genotoxic with no reproductive or developmental toxicity

• Third-Party Verification: Batch-specific Certificates of Analysis (CoA) with each shipment

Global B2B Applications Across Industries

1. Nutraceuticals & Dietary Supplements (Largest Segment)

Available Formats: Capsules, tablets, powder blends, stick packs, sublingual powders

2. Functional Foods & Beverages

3. Cosmetics & Personal Care

4. Pharmaceutical Development

• Clinical Trial Material: High-purity (≥99%) for IND applications

• Neurodegenerative Disease Research: Parkinson's, Alzheimer's studies

• Reference Standards: Certified material for analytical quality control

Regulatory Status & Global Market Access

United States

• GRAS Notice GRN 000734: Received a "no questions" letter from the FDA

• Self-Affirmed GRAS: Multiple manufacturers have self-affirmed GRAS status

• Dietary Supplement: Permitted for use in dietary supplements

European Union

• Novel Food Authorization: Authorized under Regulation (EU) 2018/462

• EFSA Safety Assessment: Concluded safe for the general population under proposed conditions of use

• NOAEL: 800 mg/kg bw/day

China

• Pre-Market Approval: Application submitted in May 2024; currently under review

• Cosmetics: Already listed in IECIC (Inventory of Existing Cosmetic Ingredients in China)

Safety Profile Summary

• Non-genotoxic with no evidence of reproductive or developmental toxicity

• Well-tolerated in humans at intake levels up to 25 mg/day

• No adverse events reported in multiple clinical trials

The China Advantage: Strategic Sourcing for B2B Buyers

China has emerged as a key global producer of L-ergothioneine, with multiple manufacturers offering high-purity (≥98%) material at competitive prices.

Key Advantages

• Advanced Production Technologies: Manufacturers utilize fermentation and biosynthesis technologies to achieve high-purity production at commercial scale

• Vertically Integrated Supply Chains: Full control from raw material sourcing to finished powder

• Competitive Pricing: Direct manufacturer pricing with flexible MOQs starting from 1 kg

• Multiple Purity Grades: ≥98%, ≥99%, and higher specifications available

• Supply Capacity: Up to 20 tons per year

Full Traceability: End-to-end quality control from fermentation to finished product

Supplier Evaluation Criteria for B2B Buyers

Storage & Handling Recommendations

Why Partner With Us?

1. Technical & Formulation Excellence

• Vertically integrated manufacturing: Full control from fermentation to finished powder

• Multiple purity grades: ≥98%, ≥99% specifications available

• Formulation support: Guidance on optimal dosage, blend compatibility, and application-specific challenges

• Regulatory expertise: Assistance with FDA, EFSA, and international regulatory requirements

2. Regulatory & Compliance Leadership

• FDA GRAS (GRN 000734) and EU Novel Food compliant

• Full documentation: Batch-specific CoA, MSDS, Certificate of Origin, stability data

• Third-party testing: Comprehensive quality control with SGS-audited verification

• Global compliance: Documentation for FDA, EFSA, and other international regulatory bodies

3. Supply Chain Security

• Scalable production capacity: From R&D samples to full container orders

• Temperature-controlled logistics: Secure global shipping

• Flexible MOQs: Starting from 1 kg

• Reliable delivery schedules: Consistent supply for your manufacturing needs

4. Customer Partnership

• Dedicated account management: Responsive service for B2B partners

• Private labeling and OEM/ODM services: Custom capsule, tablet, and powder sachet filling

• Co-development opportunities: Custom formulations for specific applications

• Competitive tiered pricing: Direct manufacturer pricing with volume discounts

Request Samples & Technical Documentation

Elevate your product lines with pharmaceutical-grade L-ergothioneine powder - a scientifically validated, premium bioactive ingredient for the global longevity, cognitive health, and skin wellness markets. Contact our B2B specialists today to:

✓ Request product samples for R&D evaluation (1 kg MOQ available)

✓ Receive comprehensive technical dossiers (CoA, MSDS, stability data)

✓ Discuss custom purity specifications (≥98%, ≥99%)

✓ Obtain competitive bulk pricing based on volume

✓ Schedule a technical consultation for formulation support

Partner with us to deliver science-backed, premium-quality L-ergothioneine solutions to your customers worldwide.

SEO Keywords: L-Ergothioneine Powder B2B, Ergothioneine Supplier, 98% EGT Bulk, Longevity Ingredient Manufacturer, Cognitive Health Supplement Raw Material, Skin Anti-Aging Active, Pharmaceutical Grade Ergothioneine, Natural Antioxidant Powder, OCTN1 Transporter Activator, China Ergothioneine Export, Bulk EGT Wholesale, Clinical-Grade Ergothioneine.